STZ
42
-2
STT
62
3
CSCO
64
6
IR
58
3
WDC
70
2
MCK
67
3
O
33
2
SE
49
2
IVZ
70
2
HSY
43
2
ZION
71
2
NDAQ
74
4
BEN
55
2
NUE
58
7
THC
47
2
PWR
56
3
PSA
35
-11
CI
48
-4
DG
74
2
MAT
50
-5
STZ
42
-2
STT
62
3
CSCO
64
6
IR
58
3
WDC
70
2
MCK
67
3
O
33
2
SE
49
2
IVZ
70
2
HSY
43
2
ZION
71
2
NDAQ
74
4
BEN
55
2
NUE
58
7
THC
47
2
PWR
56
3
PSA
35
-11
CI
48
-4
DG
74
2
MAT
50
-5
Financhill
Back

CIBC International Equity ETF Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison

Buy
65

CINT.TO
CIBC International Equity ETF

Last Price:
$23.74
Seasonality Move:
0.07%
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$61.19
Seasonality Move:
5.52%
Buy
65
CIBC International Equity ETF (CINT.TO) is a Buy

Is CIBC International Equity ETF a Buy, Sell or Hold?

  • The current CIBC International Equity ETF [CINT.TO] share price is $23.71. The Score for CINT.TO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • CINT.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CINT.TO Stock Price Chart

What is CIBC International Equity ETF's stock price today?

  • The CIBC International Equity ETF share price today is $23.71
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CINT.TO is experiencing selling pressure, which indicates risk of future bearish movement.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $61.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

CINT.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 51.43 Buy
Chaikin Money Flow: -1722 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.33 - 23.83) Buy
Bollinger Bands (100): (23.15 - 24.05) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 73.39 Buy
Chaikin Money Flow: 7836963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.19 - 56.01) Buy
Bollinger Bands (100): (52.65 - 57.43) Buy

CINT.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.58 Buy
20-day SMA: 23.67 Buy
50-day SMA: 23.8 Sell
200-day SMA: 23.37 Buy
8-day EMA: 23.59 Buy
20-day EMA: 23.63 Buy
50-day EMA: 23.69 Buy
200-day EMA: 23.53 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.6 Buy
20-day SMA: 54.21 Buy
50-day SMA: 53.61 Buy
200-day SMA: 57.94 Buy
8-day EMA: 54.44 Buy
20-day EMA: 53.99 Buy
50-day EMA: 54.1 Buy
200-day EMA: 58.28 Buy

CIBC International Equity ETF Earnings Growth & CINT.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.

CIBC International Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):